Benjamin Garmezy, MD

Benjamin Garmezy, M.D., is a board-certified medical oncologist and the Assistant Director of Genitourinary Research for Sarah Cannon Research Institute at SCRI Oncology Partners. Dr. Garmezy specializes in genitourinary (GU) oncology research. He oversees investigational therapy trials for prostate, kidney, bladder and testicular cancers and offers a variety of treatment options to patients, including chemotherapy, immunotherapy, targeted therapy and precision oncology.

Dr. Garmezy

Growing up, I knew I wanted a job where I could help others. As a medical oncologist and researcher, not only do I get to improve people’s lives through treatments that help them feel better and live longer, I also get to further the knowledge of the scientific community through research.

I offer the best emerging treatment options for patients and serve as a guide for them and their families during what is often a challenging time. I offer everything from standard-of-care cancer therapy to cutting-edge clinical trials to improve the lives of patients and their families. I make treatment decisions based on the goals, wishes and lifestyles of my patients and their families.

It’s rewarding to help a patient feel better and return to the activities they enjoy most, whether it’s a long walk, swinging a golf club, or going to dinner with friends.